Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical industry regulator over the way it has promoted its weight loss medications semaglutide (Ozempic/Wegovy) and ...

But the new Lenovo Chromebook Duet is a great reminder that ... or just someone who wants a proper browser on their tablet, the IdeaPad Duet is a great way to go… I know I’d recommend this ...

We ran our usual suite of browser-based Chromebook benchmarks and here are the scores: These are great scores! Based on those numbers alone, performance is comparable to the Lenovo Flex 5i ...

For a limited time, get this refurbished Lenovo 11.6" 100e Chromebook 2nd-Gen on sale for $59.99 (reg. $149). StackSocial prices subject to change. Unlock Exclusive Deals on the Latest Tech Products ...

Get the latest car news, reviews, and features.

Back in 2021, a new brand founded by 2009 Formula 1 champion Jenson Button and celebrity mechanic Ant Anstead revealed plans to build a low-production supercar inspired by the Lotus Type 62.

Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s ...

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...

Denmark unveiled an Nvidia-powered supercomputer that will be used by researchers from Novo Nordisk A/S and other Danish pharmaceutical companies as they seek novel drugs and smarter trial designs.

Novo Nordisk asked the Food and Drug Administration to prevent compounding pharmacies from making cheaper versions of its popular weight loss injection Wegovy and diabetes treatment Ozempic.